Concepedia

Publication | Open Access

Phase I Clinical Trial of the Immunocytokine EMD 273063 in Melanoma Patients

DOIFull Paper Access

145

Citations

27

References

2004

Year

David M. King, Mark R. Albertini, Heidi Schalch, Jacquelyn A. Hank, Jacek Gan, Jean E. Surfus, David Mahvi, Joan H. Schiller, Thomas F. Warner, KyungMann Kim,
Journal of Clinical Oncology

Abstract

Treatment with the immunocytokine EMD 273063 induced immune activation and was associated with reversible clinical toxicities at the MTD of 7.5 mg/m2/d in melanoma patients.

References

YearCitations

Page 1